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ME and My Shadow
Everyone Exposed to Methyleugenol
Whether you intend to or not, chances are
you will consume approximately 6 micro-
grams of methyleugenol (ME) today,
according to a report in this month's issue
by Dana B. Barr and colleagues ofa study
designed to measure ME in human blood _
serum [EHP 108:323-328]. ME is a com-
pound that occurs naturally in a variety of
spices and herbs, including clove oil, nutmeg,
allspice, and walnuts. In both its natural and
synthetic forms, it is an FDA-approved addi-
tive, and it is widely used as a flavoring
agent in desserts, condiments, and ciga-
rettes, as an attractant in insecticides,
and as a fragrance in perfumes and soaps.
Because of its structural similarity to other
flavorants that are known to be carcinogenic
such as safrole and estragole, ME has
come under suspicion of carcino-
genicity. Recent research, some of
which was conducted by the
National Toxicology Program
at the NIEHS, has shown
clearly that ME causes can-
cer in laboratory rodents
and suggests that it may
be a human carcinogen as
well. To accurately evalu-
ate the level of risk asso-
ciatedwith acompound,
both toxicologic and
human exposure data are
required.
The investigators-col-
laborating teams from the
ational Center for Environmental
Health at the Centers for Disease Control
FIavor fears. New
information reveals
widespread exposure
to methyleugenol, a
flavoring agent that
may well be carcino-
genic to humans.
and Prevention and from the NIEHS-
used extremely sophisticated tools and care-
fully planned methodologies to arrive at the
conclusion that low-level exposure to ME
is virtually ubiquitous in the U.S. adult 4
population. They analyzed serum sam-fl
ples from 206 adults who had partici-
pated in the Third National Health*
and Nutrition Examination Survey
(NHANES III), conducted between 1988 and 1994. With the U
sensitivity and accuracy afforded by isotope dilution gas chro-
matography-high resolution mass spectrometry, they detected ME
in 98% ofthe samples. They then used pertinent questionnaire data
from NHANES III to analyze the laboratory results for statistical
significance among a wide variety of variables. Unfortunately,
none ofthose demographic and lifestyle variables were statistically
significant markers ofME exposure. The fact that there were no
clear "smokingguns" correlating to ME exposure led the authors
to conclude that it comes from a variety of sources, including
air, water, and foods containing naturally occurring ME. They
also believe these findings are a good indicator of the preva-
lence and expected serum concentrations that are likely to be
encountered in the U.S. population.
So, like it or not, most adults in America are probably
exposed to this suspected carcinogen every day and probably
have no way of avoiding the compound altogether. Barr and
colleagues also point out that children are likely to have high-
er concentrations of ME, given their smaller size and the
nature ofsome ofthe identified commercial sources of
ME, such as candy, ice cream,
chewing gum, and other sweets.
,Therefore, they say, ME exposure
and risk assessment in children is a
rucial area inwhich to focus future studies.
The authors are cautious to draw no further
conclusions beyondwhat their datawarrant-that
the appropriate information is now in place to
allow more comprehensive assessment of the
risk associated with human exposure to ME.
However, it seems clear that the end result of
that assessment could be the eventual elimination of
ME from the commercial marketplace. That
would at least remove the possibility of ME
exposure from avoidable sources, substantially
reducing the overall prevalence ofthe compound
in the population and the level ofrisk it poses to
human health. -Ernie Hood
Smoking-induced Leukemia
How Much Is Benzeneto Blame?
Benzene, known to cause leukemia, is present in cigarette smoke.
However, although smokers are one-and-a-half to two times more
likely to develop leukemia than nonsmokers, the degree to which
the risk ofleukemia can be attributed to the low doses ofbenzene
in cigarette smoke is uncertain. Also uncertain is the validity oflin-
ear models ofdose-response with respect to benzene and leukemia,
particularly at doses lower than those encountered in the workplace
(and studied) in the past. Some scientists have been concerned that
linear models-which link an increase in benzene exposure to a
corresponding increase in disease-may overestimate the risk of
leukemia.
In this month's issue, Jeffrey E. Korte and colleagues from the
University of North Carolina at Chapel Hill compared published
eidemiological data to their own risk assessment predic-
tions to determine the proportion of all types of
leukemia and acute myeloid leukemia (AML) attribut-
able to benzene in cigarette smoke [EHP
108:333-339]. They used linear models and one qua-
dratic model to formulate their predictions, which
allowed them to test linear models' ability to accurately
predict occupational and nonoccupational risk from
benzene exposure. This may be important to the future
of setting exposure limits in facilities where benzene is
used.
The researchers determined the proportion of smoking-
induced leukemia deaths causedby benzenebyfollowing a five-
step process in which they calculated the lifetime leukemia risk
from smoking, determined the potency of benzene in causing
leukemia, estimated the benzene dose from smoking, character-
ized the low-dose risk of leukemia from benzene, and compared
the predicted lifetime risk of leukemia from benzene in cigarettes
with the observed risk due to smoking. The applied their calcula-
tions to light (20 cigarettes daily) and heavy (40 or more cigarettes
daily) smokers, with comparisons to those who never smoked.
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